Figure 3.
Progression free survival and overall survival in patients stage I–IV with KRAS wild type and KRAS mutated tumours (A,B) and patients with KRAS wild type, KRAS G12C, and KRAS non-G12C (C,D).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.